NCT03262103 2022-09-10Neoadjuvant Hiltonol® (PolyICLC) for Prostate CancerIcahn School of Medicine at Mount SinaiPhase 1 Completed13 enrolled
NCT00398073 2017-03-16Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV MelanomaMemorial Sloan Kettering Cancer CenterPhase 1 Completed35 enrolled 9 charts